Clinical Trials
3 trialsNCT02029950 2020-10-14
Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 1 Completed
NCT00669578 2019-12-30
CC-4047 in Treating Patients With Myelofibrosis
Mayo Clinic
Phase 1/2 Completed
NCT00949364 2017-09-25
Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
University of Ulm
Phase 2 Completed